Albania vs Czechia: Cause of death, by non-communicable diseases, ages 0-4
Albania
32.5%
in 2021
Czechia
33.4%
in 2021
Albania rank
84th
Czechia rank
81st
Cause of death, by non-communicable diseases, ages 0-4 over time
- Albania
- Czechia
How they compare
Czechia currently reports 33.4% against 32.5% in Albania, a difference of 0.9%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Czechia ahead.
Albania ranks 84th and Czechia ranks 81st of 185 countries.
Across the 3 decades both report, Albania averaged higher in 1 and Czechia in 2.
Head to head by decade
| Decade | Albania | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.3% | 32.7% | 6.5% | Czechia |
| 2010s | 35.3% | 35.0% | 0.3% | Albania |
| 2020s | 32.5% | 32.8% | 0.3% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Albania or Czechia?
- Czechia, at 33.4% against 32.5% in Albania as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Albania and Czechia?
- 0.9%, with Czechia ahead.
- How many years of comparable data are there for Albania and Czechia?
- 6 years are reported by both, from 2000 to 2021.
- How do Albania and Czechia rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Albania ranks 84th and Czechia ranks 81st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.